{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:04:33Z","timestamp":1778022273610,"version":"3.51.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1023\/a:1020284302718","type":"journal-article","created":{"date-parts":[[2003,3,15]],"date-time":"2003-03-15T13:37:24Z","timestamp":1047735444000},"page":"697-709","source":"Crossref","is-referenced-by-count":27,"title":["Complex Gangliosides as Autoantibody Targets at the Neuromuscular Junction in Miller Fisher Syndrome: A Current Perspective"],"prefix":"10.1007","volume":"27","author":[{"given":"Graham M.","family":"O'Hanlon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland W. M.","family":"Bullens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap J.","family":"Plomp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh J.","family":"Willison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"378351_CR1","first-page":"3","volume":"3","author":"N. Yuki","year":"1998","unstructured":"Yuki, N. 1998. Anti-ganglioside antibody and neuropathy: Review of our research. J. Periph. Nerv. Sys. 3:3-18.","journal-title":"J. Periph. Nerv. Sys."},{"key":"378351_CR2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<800::AID-MUS2>3.0.CO;2-F","volume":"22","author":"R. H. Quarles","year":"1999","unstructured":"Quarles, R. H. and Weiss, M. D. 1999. Autoantibodies associated with peripheral neuropathy. Muscle Nerve 22:800-822.","journal-title":"Muscle Nerve"},{"key":"378351_CR3","first-page":"259","volume-title":"Campylobacter","author":"H. J. Willison","year":"2000","unstructured":"Willison, H. J. and O'Hanlon, G. M. 2000. Anti-glycosphingolipid antibodies and Guillain-Barre syndrome. In: Campylobacter, pp. 259-285. Editors: I. Nachamkin and M. J. Blaser. ASM Press, Washington, D.C."},{"key":"378351_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-5728(99)00213-1","volume":"100","author":"H. J. Willison","year":"1999","unstructured":"Willison, H. J. and O'Hanlon, G. M. 1999. The immunopathogenesis of Miller Fisher syndrome. J. Neuroimmunol. 100:3-12.","journal-title":"J. Neuroimmunol."},{"key":"378351_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","volume":"255","author":"M. Fisher","year":"1956","unstructured":"Fisher, M. 1956. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med. 255:57-65.","journal-title":"N. Engl. J. Med."},{"key":"378351_CR6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","volume":"31","author":"A. Chiba","year":"1992","unstructured":"Chiba, A., Kusunoki, S., Shimizu, T., and Kanazawa, I. 1992. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31:677-679.","journal-title":"Ann. Neurol."},{"key":"378351_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-5728(93)90239-U","volume":"46","author":"H. J. Willison","year":"1993","unstructured":"Willison, H. J. and Kennedy, P. G. E. 1993. Gangliosides and bacterial toxins in Guillain-Barre-syndrome. J. Neuroimmunol. 46:105-112.","journal-title":"J. Neuroimmunol."},{"key":"378351_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/15569549909036016","volume":"18","author":"C.-L. Schengrund","year":"1999","unstructured":"Schengrund, C.-L. 1999. What is the cell surface receptor(s) for the different serotypes of botulinum neurotoxin? J. Toxicol. Tox. Rev. 18:35-44.","journal-title":"J. Toxicol. Tox. Rev."},{"key":"378351_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/mpat.1998.0214","volume":"25","author":"S. Kozaki","year":"1998","unstructured":"Kozaki, S., Kamata, Y., Watarai, S., Nishiki, T.-I., and Mochida, S. 1998. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. Microb. Pathog. 25:91-99.","journal-title":"Microb. Pathog."},{"key":"378351_CR10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<640::AID-MUS14>3.0.CO;2-#","volume":"22","author":"A. Uncini","year":"1999","unstructured":"Uncini, A. and Lugaresi, A. 1999. Fisher syndrome with tetraparesis and antibody to GQ1b: Evidence for motor nerve terminal block. Muscle Nerve 22:640-644.","journal-title":"Muscle Nerve"},{"key":"378351_CR11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0960-8966(01)00296-6","volume":"12","author":"I. Wirguin","year":"2002","unstructured":"Wirguin, I., Ifergane, G., Almog, Y., Lieberman, D., Bersudsky, M., and Herishanu, Y. O. 2002. Presynaptic neuromusculat transmission block in Guillain-Barre syndrome associated with anti-GQ1b antibodies. Neuromuscul. Disord. 12:292-293.","journal-title":"Neuromuscul. Disord."},{"key":"378351_CR12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","volume":"352","author":"A. F. Hahn","year":"1998","unstructured":"Hahn, A. F. 1998. Guillain-Barre syndrome. Lancet 352: 635-641.","journal-title":"Lancet"},{"key":"378351_CR13","first-page":"95","volume":"3","author":"A. H. Ropper","year":"1994","unstructured":"Ropper, A. H. 1994. Miller Fisher syndrome and other acute variants of Guillain-Barre-syndrome. Baillieres Clin. Neurol. 3:95-106.","journal-title":"Baillieres Clin. Neurol."},{"key":"378351_CR14","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","volume":"176","author":"R. A. C. Hughes","year":"1997","unstructured":"Hughes, R. A. C. and Rees, J. H. 1997. Clinical and epidemiologic features of Guillain-Barre syndrome. J. Infect. Dis. 176: S92-S98.","journal-title":"J. Infect. Dis."},{"key":"378351_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<239::AID-MUS13>3.0.CO;2-X","volume":"21","author":"J. P. Ter Bruggen","year":"1998","unstructured":"Ter Bruggen, J. P., van der Mech\u00e9, F. G. A., De Jager, A. E. J., and Polman, C. H. 1998. Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barre syndrome. Muscle Nerve 21:239-242.","journal-title":"Muscle Nerve"},{"key":"378351_CR16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.56.2.204","volume":"56","author":"H. J. Willison","year":"1993","unstructured":"Willison, H. J., Veitch, J., Paterson, G., and Kennedy, P. G. E. 1993. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry 56:204-206.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"378351_CR17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/WNL.43.2.414","volume":"43","author":"N. Yuki","year":"1993","unstructured":"Yuki, N., Sato, S., Tsuji, S., Ohsawa, T., and Miyatake, T. 1993. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 43:414-417.","journal-title":"Neurology"},{"key":"378351_CR18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0022-510X(97)00312-2","volume":"155","author":"M. Carpo","year":"1998","unstructured":"Carpo, M., Pedotti, R., Lolli, F., Pitrola, A., Allaria, S., Scarlato, G., and Nobileorazio, E. 1998. Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy. J. Neurol. Sci. 155:186-191.","journal-title":"J. Neurol. Sci."},{"key":"378351_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0165-5728(94)90042-6","volume":"50","author":"H. J. Willison","year":"1994","unstructured":"Willison, H. J. and Veitch, J. 1994. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller-Fisher-syndrome. J. Neuroimmunol. 50:159-165.","journal-title":"J. Neuroimmunol."},{"key":"378351_CR20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/01616412.1998.11740573","volume":"20","author":"K. Mizoguchi","year":"1998","unstructured":"Mizoguchi, K. 1998. Anti-GQ1b IgG antibody activities related to the severity of Miller Fisher syndrome. Neurol. Res. 20: 617-624.","journal-title":"Neurol. Res."},{"key":"378351_CR21","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","volume":"43","author":"A. Chiba","year":"1993","unstructured":"Chiba, A., Kusunoki, S., Obata, H., Machinami, R., and Kanazawa, I. 1993. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: Clinical and immunohistochemical studies. Neurology 43:1911-1917.","journal-title":"Neurology"},{"key":"378351_CR22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0165-5728(97)00197-5","volume":"82","author":"A. A. Ilyas","year":"1998","unstructured":"Ilyas, A. A., Cook, S. D., Mithen, F. A., Taki, T., Kasama, T., Handa, S., Hamasaki, H., Singhal, B. S., Li, S. C., and Li, Y. T. 1998. Antibodies to GT1a ganglioside in patients with Guillain-Barre syndrome. J. Neuroimmunol. 82:160-167.","journal-title":"J. Neuroimmunol."},{"key":"378351_CR23","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1212\/WNL.44.12.2395","volume":"44","author":"H. J. Willison","year":"1994","unstructured":"Willison, H. J., Almemar, A., Veitch, J., and Thrush, D. 1994. Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 Gangliosides. Neurology 44:2395-2397.","journal-title":"Neurology"},{"key":"378351_CR24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jnnp.65.5.799","volume":"65","author":"K. Kashihara","year":"1998","unstructured":"Kashihara, K., Shiro, Y., Koga, M., and Yuki, N. 1998. IgG anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry 65:799.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"378351_CR25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(98)00016-2","volume":"86","author":"M. Koga","year":"1998","unstructured":"Koga, M., Yuki, N., Ariga, T., Morimatsu, M., and Hirata, K. 1998. Is IgG anti-GT1a antibody associated with pharyngealcervical-brachial weakness or oropharyngeal palsy in Guillain-Barre syndrome? J. Neuroimmunol. 86:74-79.","journal-title":"J. Neuroimmunol."},{"key":"378351_CR26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jnnp.61.6.649","volume":"61","author":"C. P. O'Leary","year":"1996","unstructured":"O'Leary, C. P., Veitch, J., Durward, W. F., Thomas, A. M., Rees, J. H., and Willison, H. J. 1996. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J. Neurol. Neurosurg. Psychiatry 61:649-651.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"378351_CR27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jnnp.66.4.513","volume":"66","author":"M. Koga","year":"1999","unstructured":"Koga, M., Yuki, N., and Hirata, K. 1999. Antiganglioside antibody in patients with Guillain-Barre syndrome who show bulbar palsy as an initial symptom. J. Neurol. Neurosurg. Psychiatry 66:513-516.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"378351_CR28","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1172\/JCI118529","volume":"97","author":"H. J. Willison","year":"1996","unstructured":"Willison, H. J., O'Hanlon, G. M., Paterson, G., Veitch, J., Wilson, G., Roberts, M., Tang, T., and Vincent, A. 1996. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J. Clin. Invest. 97: 1155-1164.","journal-title":"J. Clin. Invest."},{"issue":"suppl.","key":"378351_CR29","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/ana.410270708","volume":"27","author":"D. E. McFarlin","year":"1990","unstructured":"McFarlin, D. E. 1990. Immunological parameters in Guillain-Barre syndrome. Ann. Neurol. 27(suppl.):S25-S29.","journal-title":"Ann. Neurol."},{"key":"378351_CR30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.410370218","volume":"37","author":"B. C. Jacobs","year":"1995","unstructured":"Jacobs, B. C., Endtz, H. P., van der Mech\u00e9, F. G. A., Hazenberg, M. P., Achtereekte, H. A. M., and van Doorn, P. A. 1995. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter-jejuni from patients with Miller-Fishersyndrome. Ann. Neurol. 37:260-264.","journal-title":"Ann. Neurol."},{"key":"378351_CR31","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/iai.65.10.4038-4042.1997","volume":"65","author":"A. Neisser","year":"1997","unstructured":"Neisser, A., Bernheimer, H., Berger, T., Moran, A. P., and Schwerer, B. 1997. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect. Immunol. 65:4038-4042.","journal-title":"Infect. Immunol."},{"key":"378351_CR32","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1086\/513800","volume":"176","author":"N. Yuki","year":"1997","unstructured":"Yuki, N. 1997. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barre syndrome and Miller Fisher syndrome. J. Infect. Dis. 176:S150-S153.","journal-title":"J. Infect. Dis."},{"key":"378351_CR33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0165-5728(97)00110-0","volume":"79","author":"B. C. Jacobs","year":"1997","unstructured":"Jacobs, B. C., Endtz, H. P., van der Mech\u00e9, F. G. A., Hazenberg, M. P., deKlerk, M. A., and van Doorn, P. A. 1997. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barre and Miller Fisher syndrome. J. Neuroimmunol. 79:62-68.","journal-title":"J. Neuroimmunol."},{"key":"378351_CR34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/infdis\/175.3.729","volume":"175","author":"B. C. Jacobs","year":"1997","unstructured":"Jacobs, B. C., Hazenberg, M. P., van Doorn, P. A., Endtz, H. P., and van der Mech\u00e9, F. G. A. 1997. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barre or Miller Fisher syndrome. J. Infect. Dis. 175:729-733.","journal-title":"J. Infect. Dis."},{"key":"378351_CR35","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1128\/iai.64.8.2945-2949.1996","volume":"64","author":"S. Salloway","year":"1996","unstructured":"Salloway, S., Mermel, L. A., Seamans, M., Aspinall, G. O., Shin, J. E. N., Kurjanczyk, L. A., and Penner, J. L. 1996. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. Infect. Immunol. 64:2945-2949.","journal-title":"Infect. Immunol."},{"key":"378351_CR36","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/513778","volume":"176","author":"J. L. Penner","year":"1997","unstructured":"Penner, J. L. and Aspinall, G. O. 1997. Diversity of lipopolysaccharide structures in Campylobacter jejuni. J. Infect. Dis. 176:S135-S138.","journal-title":"J. Infect. Dis."},{"key":"378351_CR37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0008-6215(97)00259-0","volume":"305","author":"J. E. N. Shin","year":"1997","unstructured":"Shin, J. E. N., Ackloo, S., Mainkar, A. S., Monteiro, M. M. A., Pang, H., Penner, J. L., and Aspinall, G. O. 1997. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain. Carbohydr. Res. 305: 223-232.","journal-title":"Carbohydr. Res."},{"key":"378351_CR38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI6837","volume":"104","author":"C. S. Goodyear","year":"1999","unstructured":"Goodyear, C. S., O'Hanlon, G. M., Plomp, J. J., Wagner, E. R., Morrison, I., Veitch, J., Cochrane, L., Bullens, R. W. M., Molenaar, P. C., Conner, J., and Willison, H. J. 1999. Monoclonal antibodies raised against Guillain Barr\u00e9 syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyse nerve muscle preparations. J. Clin. Invest. 104:697-708.","journal-title":"J. Clin. Invest."},{"key":"378351_CR39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(96)01123-7","volume":"745","author":"A. Chiba","year":"1997","unstructured":"Chiba, A., Kusunoki, S., Obata, H., Machinami, R., and Kanazawa, I. 1997. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 745:32-36.","journal-title":"Brain Res."},{"key":"378351_CR40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","volume":"387","author":"K. Simons","year":"1997","unstructured":"Simons, K. and Ikonen, E. 1997. Functional rafts in cell membranes. Nature 387:569-572.","journal-title":"Nature"},{"key":"378351_CR41","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1073\/pnas.92.11.5087","volume":"92","author":"T. Mutoh","year":"1995","unstructured":"Mutoh, T., Tokuda, A., Miyadai, T., Hamaguchi, M., and Fujiki, N. 1995. Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc. Natl. Acad. Sci. U.S.A. 92: 5087-5091.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"378351_CR42","doi-asserted-by":"crossref","unstructured":"Thomas, P. D. and Brewer, G. J. 1990. Gangliosides and synaptic transmission. Biochem. Biophys. Acta 277-289.","DOI":"10.1016\/0304-4157(90)90013-3"},{"key":"378351_CR43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1531-8249(199902)45:2<189::AID-ANA9>3.0.CO;2-T","volume":"45","author":"J. J. Plomp","year":"1999","unstructured":"Plomp, J. J., Molenaar, P. C., O'Hanlon, G. M., Jacobs, B. C., Veitch, J., Daha, M. R., van Doorn, P. A., van der Mech\u00e9, F. G. A., Vincent, A., Morgan, B. P., and Willison, H. J. 1999. Miller Fisher anti-GQ1b antibodies: A-latrotoxin-like effects on motor end plates. Ann. Neurol. 45:189-199.","journal-title":"Ann. Neurol."},{"key":"378351_CR44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1567-5769(00)00043-6","volume":"1","author":"T. Miwa","year":"2001","unstructured":"Miwa, T. and Song, W. C. 2001. Membrane complement regulatory proteins: Insight from animal studies and relevance to human diseases. Int. Immunopharmacol. 1:445-459.","journal-title":"Int. Immunopharmacol."},{"key":"378351_CR45","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1073\/pnas.89.8.3330","volume":"89","author":"O. D. Uchitel","year":"1992","unstructured":"Uchitel, O. D., Protti, D. A., Sanchez, V., Cherksey, B. D., Sugimori, M., and Llinas, R. 1992. P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc. Natl. Acad. Sci. U.S.A. 89:3330-3333.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"378351_CR46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.1999.tb11284.x","volume":"868","author":"W. A. Catterall","year":"1999","unstructured":"Catterall, W. A. 1999. Interactions of presynaptic Ca2+ channels and snare proteins in neurotransmitter release. [Review] [84 refs]. Ann. N. Y. Acad. Sci. 868:144-159.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"378351_CR47","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/375645a0","volume":"375","author":"T. C. Sudhof","year":"1995","unstructured":"Sudhof, T. C. 1995. The synaptic vesicle cycle: A cascade of protein-protein interactions. Nature 375:645-653.","journal-title":"Nature"},{"key":"378351_CR48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","volume":"64","author":"S. J. Wood","year":"2001","unstructured":"Wood, S. J. and Slater, C. R. 2001. Safety factor at the neuromuscular junction. Prog. Neurobiol. 64:393-429.","journal-title":"Prog. Neurobiol."},{"key":"378351_CR49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1113\/jphysiol.1992.sp019429","volume":"458","author":"J. J. Plomp","year":"1992","unstructured":"Plomp, J. J., van Kempen, G. T., and Molenaar, P. C. 1992. Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha-bungarotoxin-treated rats. J. Physiol. 458:487-499.","journal-title":"J. Physiol."},{"key":"378351_CR50","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1016\/S0021-9258(17)39364-X","volume":"260","author":"L. J. Cruz","year":"1985","unstructured":"Cruz, L. J., Gray, W. R., Olivera, B. M., Zeikus, R. D., Kerr, L., Yoshikami, D., and Moczydlowski, E. 1985. Conus geographus toxins that discriminate between neuronal and muscle sodium channels. J. Biol. Chem. 260:9280-9288.","journal-title":"J. Biol. Chem."},{"key":"378351_CR51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3940(95)12155-2","volume":"201","author":"B. Buchwald","year":"1995","unstructured":"Buchwald, B., Weishaupt, A., Toyka, K. V., and Dudel, J. 1995. Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci. Lett. 201:163-166.","journal-title":"Neurosci. Lett."},{"key":"378351_CR52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-5728(01)00373-3","volume":"119","author":"N. Ortiz","year":"2001","unstructured":"Ortiz, N., Rosa, R., Gallardo, E., Illa, I., Tomas, J., Aubry, J., and Santafe, M. 2001. IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: Effects on neurotransmitter release. J. Neuroimmunol. 119:114-123.","journal-title":"J. Neuroimmunol."},{"key":"378351_CR53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0140-6736(94)92694-8","volume":"343","author":"M. Roberts","year":"1994","unstructured":"Roberts, M., Willison, H., Vincent, A., and Newsomdavis, J. 1994. Serum factor in Miller-Fisher variant of Guillain-Barresyndrome and neurotransmitter release. Lancet 343:454-455.","journal-title":"Lancet"},{"key":"378351_CR54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mus.10060","volume":"25","author":"B. C. Jacobs","year":"2002","unstructured":"Jacobs, B. C., Bullens, R. W. M., O'Hanlon, G. M., Ang, C. W., Willison, H. J., and Plomp, J. J. 2002. Detection and prevalence of alpha-latrotoxin-like effects of Guillain-Barr\u00e9 syndrome sera. Muscle Nerve 25:549-558.","journal-title":"Muscle Nerve"},{"key":"378351_CR55","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/1097-4598(200007)23:7<1035::AID-MUS5>3.0.CO;2-R","volume":"23","author":"R. W. M. Bullens","year":"2000","unstructured":"Bullens, R. W. M., O'Hanlon, G. M., Goodyear, C. S., Molenaar, P., Conner, J., Willison, H. J., and Plomp, J. J. 2000. Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplates. Muscle Nerve 23:1035-1043.","journal-title":"Muscle Nerve"},{"key":"378351_CR56","doi-asserted-by":"crossref","first-page":"23239","DOI":"10.1074\/jbc.271.38.23239","volume":"271","author":"B. A. Davletov","year":"1996","unstructured":"Davletov, B. A., Shamotienko, O. G., Lelianova, V. G., Grishin, E. V., and Ushkaryov, Y. A. 1996. Isolation and biochemical characterization of a Ca2+-independent alpha-latrotoxinbinding protein. J. Biol. Chem. 271:23239-23245.","journal-title":"J. Biol. Chem."},{"key":"378351_CR57","first-page":"990","volume":"44","author":"C. S. Goodyear","year":"1998","unstructured":"Goodyear, C. S., O'Hanlon, G. M., Plomp, J. J., Morrison, I., Veitch, J., Conner, J., Molenaar, P. C., and Willison, H. J. 1998. Anti-GQ1b ganglioside antibodies cloned from mice immunized with Miller Fisher syndrome-associated strains of Campylobacter jejuni lipopolysaccharide induce neuromuscular transmission block. Ann. Neurol. 44:990.","journal-title":"Ann. Neurol."},{"key":"378351_CR58","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/122.5.807","volume":"122","author":"K. Paparounas","year":"1999","unstructured":"Paparounas, K., O'Hanlon, G. M., O'Leary, C. P., Rowan, E. G., and Willison, H. J. 1999. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Brain 122:807-816.","journal-title":"Brain"},{"key":"378351_CR59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0169-328X(97)00189-7","volume":"50","author":"P. F. Stahel","year":"1997","unstructured":"Stahel, P. F., Kossmann, T., Morganti-Kossmann, M. C., Hans, V. H. J., and Barnum, S. R. 1997. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats. Mol. Brain Res. 50:205-212.","journal-title":"Mol. Brain Res."},{"key":"378351_CR60","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0306-4522(98)00372-8","volume":"88","author":"H. Osaka","year":"1999","unstructured":"Osaka, H., McGinty, A., Hoepken, U. E., Lu, B., Gerard, C., and Pasinetti, G. M. 1999. Expression of C5a receptor in mouse brain: Role in signal transduction and neurodegeneration. Neuroscience 88:1073-1082.","journal-title":"Neuroscience"},{"key":"378351_CR61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0166-2236(98)01390-3","volume":"22","author":"S. Nataf","year":"1999","unstructured":"Nataf, S., Stahel, P. F., Davoust, N., and Barnum, S. R. 1999. Complement anaphylatoxin receptors on neurons: New tricks for old receptors? Trends Neurosci. 22:397-402.","journal-title":"Trends Neurosci."},{"key":"378351_CR62","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/brain\/124.5.893","volume":"124","author":"G. M. O'Hanlon","year":"2001","unstructured":"O'Hanlon, G. M., Plomp, J. J., Chakrabarti, M., Morrison, I., Wagner, E. R., Goodyear, C. S., Yin, X., Trapp, B. D., Conner, J., Molenaar, P. C., Stewart, S., Rowan, E. G., and Willison, H. J. 2001. Anti-GQ1b ganglioside antibodies mediate complementdependent destruction of the motor nerve terminal. Brain 124: 893-906.","journal-title":"Brain"},{"key":"378351_CR63","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1126\/science.172.3984.733","volume":"172","author":"M. Okamoto","year":"1971","unstructured":"Okamoto, M., Longenecker, H. E., Riker, W. F., Jr., and Song, S. K. 1971. Destruction of mammalian motor nerve terminals by black widow spider venom. Science 172:733-736.","journal-title":"Science"},{"key":"378351_CR64","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1523\/JNEUROSCI.21-11-03819.2001","volume":"21","author":"D. Rochon","year":"2001","unstructured":"Rochon, D., Rousse, I., and Robitaille, R. 2001. Synapse-glia interactions at the mammalian neuromuscular junction. J. Neurosci. 21:3819-3829.","journal-title":"J. Neurosci."},{"key":"378351_CR65","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0166-2236(00)01674-X","volume":"23","author":"R. D. Fields","year":"2000","unstructured":"Fields, R. D. and Stevens, B. 2000. ATP: An extracellular signaling molecule between neurons and glia. Trends Neurosci. 23:625-633.","journal-title":"Trends Neurosci."},{"key":"378351_CR66","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1517\/13543776.8.12.1707","volume":"8","author":"G. J. Wells","year":"1998","unstructured":"Wells, G. J. and Bihovsky, R. 1998. Calpain inhibitors as potential treatment for stroke and other neurodegenerative diseases: Recent trends and developments. Expert Opin. Therapeutic Patents 8:1707-1727.","journal-title":"Expert Opin. Therapeutic Patents"},{"key":"378351_CR67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/bbrc.1998.8085","volume":"245","author":"Y. Ono","year":"1998","unstructured":"Ono, Y., Sorimachi, H., and Suzuki, K. 1998. Structure and physiology of calpain, an enigmatic protease. Biochem. Biophys. Res. Commun. 245:289-294.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"378351_CR68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(199903)178:3<311::AID-JCP5>3.0.CO;2-T","volume":"178","author":"M. K. T. Squier","year":"1999","unstructured":"Squier, M. K. T., Sehnert, A. J., Sellins, K. S., Malkinson, A. M., Takano, E., and Cohen, J. J. 1999. Calpain and calpastatin regulate neutrophil apoptosis. J. Cell. Physiol. 178:311-319.","journal-title":"J. Cell. Physiol."},{"key":"378351_CR69","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jnr.490290310","volume":"29","author":"N. L. Banik","year":"1991","unstructured":"Banik, N. L., DeVries, G. H., Neuberger, T., Russell, T., Chakrabarti, A. K., and Hogan, E. L. 1991. Calcium-activated neutral proteinase (CANP; calpain) activity in Schwann cells: Immunofluorescence localization and compartmentation of muand mCANP. J. Neurosci. Res. 29:346-354.","journal-title":"J. Neurosci. Res."},{"key":"378351_CR70","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0006-8993(91)91471-C","volume":"564","author":"M. Mata","year":"1991","unstructured":"Mata, M., Kupina, N., and Fink, D. J. 1991. Calpain II in rat peripheral nerve. Brain Res. 564:328-331.","journal-title":"Brain Res."},{"key":"378351_CR71","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0006-8993(95)00949-Q","volume":"697","author":"Z. Li","year":"1995","unstructured":"Li, Z. and Banik, N. L. 1995. The localization of mcalpain in myelin: Immunocytochemical evidence in different areas of rat brain and nerves. Brain Res. 697:112-121.","journal-title":"Brain Res."},{"key":"378351_CR72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1097-4695(199606)30:2<177::AID-NEU1>3.0.CO;2-2","volume":"30","author":"J. Li","year":"1996","unstructured":"Li, J., Grynspan, F., Berman, S., Nixon, R., and Bursztajn, S. 1996. Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord. J. Neurobiol. 30:177-191.","journal-title":"J. Neurobiol."},{"key":"378351_CR73","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/neu.1997.14.419","volume":"14","author":"W. L. Maxwell","year":"1997","unstructured":"Maxwell, W. L., Povlishock, J. T., and Graham, D. L. 1997. A mechanistic analysis of nondisruptive axonal injury: A review. J. Neurotrauma 14:419-440.","journal-title":"J. Neurotrauma"},{"key":"378351_CR74","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1523\/JNEUROSCI.20-19-07290.2000","volume":"20","author":"G. David","year":"2000","unstructured":"David, G. and Barrett, E. F. 2000. Stimulation-evoked increases in cytosolic [Ca(2+)] in mouse motor nerve terminals are limited by mitochondrial uptake and are temperature-dependent. J. Neurosci. 20:7290-7296.","journal-title":"J. Neurosci."},{"key":"378351_CR75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01217918","volume":"7","author":"A. Gorio","year":"1978","unstructured":"Gorio, A., Rubin, L. L., and Mauro, A. 1978. Double mode of action of black widow spider venom on frog neuromuscular junction. J. Neurocytol. 7:193-202.","journal-title":"J. Neurocytol."},{"key":"378351_CR76","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF00318572","volume":"90","author":"W. Bruck","year":"1995","unstructured":"Bruck, W., Bruck, Y., Diederich, U., and Piddlesden, S. J. 1995. The membrane attack complex of complement mediates peripheral nervous system demyelination in vitro. Acta Neuropathol. 90:601-607.","journal-title":"Acta Neuropathol."},{"key":"378351_CR77","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1046\/j.1471-4159.1999.0732321.x","volume":"73","author":"S. M. Dashiell","year":"1999","unstructured":"Dashiell, S. M. and Koski, C. L. 1999. Sublytic terminal complement complexes decrease P0 Gene expression in Schwann cells. J. Neurochem. 73:2321-2330.","journal-title":"J. Neurochem."},{"key":"378351_CR78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1098-1136(200004)30:2<187::AID-GLIA8>3.0.CO;2-7","volume":"30","author":"S. M. Dashiell","year":"2000","unstructured":"Dashiell, S. M., Rus, H., and Koski, C. L. 2000. Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis. Glia 30: 187-198.","journal-title":"Glia"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020284302718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1020284302718\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020284302718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:06:22Z","timestamp":1751864782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1020284302718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":78,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["378351"],"URL":"https:\/\/doi.org\/10.1023\/a:1020284302718","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}